Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-03-27 17:05 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,999
+50,000 vol $9.04 each |
139,000 | |
Filed 2022-10-27 13:31 Tx date 2022-06-29 |
$EPI
ESSA Pharma Inc. |
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,500 vol |
89,000 | |
Filed 2020-12-15 13:45 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$115,500
+16,500 vol $7.00 each |
66,500 | |
Filed 2019-11-01 15:44 Tx date 2019-10-30 |
$EPI
ESSA Pharma Inc. |
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$116,750
+25,000 vol $4.67 each |
50,000 | |
Filed 2019-10-16 13:55 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,750
+25,000 vol $3.23 each |
25,000 | |
Filed 2019-10-16 13:53 Tx date 2019-07-31 |
$EPI
ESSA Pharma Inc. |
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-08-09 13:42 Tx date 2019-07-31 |
$EPI
ESSA Pharma Inc. |
Thorell, Ann Marella
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,881 |